Flexicare Lanka – a fully owned subsidiary of Flexicare Group, U.K. – recently inaugurated its state-of-the-art modern manufacturing facility in Bandaragama which is expected to revolutionise medical products manufacturing in Sri Lanka. With a total investment of over USD 15 million, the new innovative medical devices manufacturing plant begins its first phase of operations in the country with a current workforce of 150 employees.
The Grand Opening Ceremony at Bandaragama commenced with the traditional Sri Lankan welcome of Kandyan dancers moving to the beat of ceremonial drums as the esteemed guests were guided in procession to the main lobby. The Flexicare manufacturing plant was officially inaugurated and symbolically declared open as the Chief Guest – Basil Rajapakse, Finance Minister of The Democratic Socialists Republic of Sri Lanka performed the honours of cutting the ribbon and kickstarting the event.
The inaugural event was also graced by the presence of Guests of Honour Sara Hulton – British High Commissioner to Sri Lanka and Keheliya Rambukwella – Minister of Health and Indigenous Medicine, Special Guest and Former Minister of Health Dr Rajitha Senarathna, The Board of Directors of Flexicare Lanka, distinguished media, and several other honourable invitees. Following an enthralling cultural entertainment performance by the Channa Upuli dance ensemble, the esteemed guests were taken through
a virtual tour of the factory and later, on an exclusive inspection tour of the facility.
Addressing the gathering at the event, Chief Guest Basil Rajapakse stated: “I would like to extend my
heartfelt gratitude and appreciation to Flexicare – a globally recognised medical device manufacturer –
for choosing to invest in Sri Lanka especially amidst a global pandemic. It brings us immense joy and
pride to witness Flexicare’s life-sustaining and lifesaving products being manufactured in our very own
country and going on to make a significant impact on people’s lives on a global scale.”
Furthermore, Keheliya Rambukwella – Minister of Health and Indigenous Medicine stated: “This is the
first time in the history of the country that such a futuristic facility has been established with a vision to
export and cater to the healthcare industry in Sri Lanka. We’re extremely proud to have a manufacturing
plant of international recognition and have absolute confidence that Flexicare will revolutionise and
elevate the Sri Lankan healthcare sector. Flexicare’s investment goes a long way in terms of employment
opportunities, development of local resources, foreign exchange and the nation’s overall economic health.
We sincerely look forward to many more such investments, particularly in the health sector, and assure
that Sri Lanka will give the best possible background for the same.”
Speaking on behalf of Flexicare and concluding the Grand Opening Ceremony, Hash Poormand –
Managing Director of Flexicare Group stated: “Immense perseverance, dedication and hard work have led
us here as we bring to life the promise of true equity, inclusion and development by unlocking the
potential of everything that this beautiful island nation has to offer. The positive catalytic effect of
Flexicare has already resulted in the employment of 150 Sri Lankans and is soon expected to grow into a
workforce of 600 employees within the first phase of the project itself. Our commitment is to invest in the
training and socio-economic development of Sri Lanka’s homegrown medical engineers, which we
believe will have a tremendous ripple effect throughout the country.”
Flexicare’s New Innovative Medical Devices Manufacturing Facility at Bandaragama began construction
in 2019 and is now fully operational with 90% of the production intended for exports. Flexicare is
expected to ramp up the workforce to 600 employees in the first phase with a second expansion in due
Flexicare is a privately owned leading designer, manufacturer and supplier of medical devices backed by
over 30 years of experience in the healthcare sector. Headquartered in the UK, Flexicare has expanded its
international reach to over 110 countries, supported by wholly owned subsidiaries and scientific offices in
the USA, South America, Netherlands, Germany, Italy, Turkey, Jordan, Egypt, India, Sri Lanka,
Malaysia, Korea, China, Japan and Australia. With state of the art, purpose-built manufacturing facilities
in key markets, the company has continued to expand its operations and capabilities that serve to provide
a vertically integrated business model that has full control over the production and supply chain of its
anaesthesia and respiratory portfolio.
For further information, please visit www.flexicare.com.